Gyre Therapeutics, Inc. GYRE Gyre Pharmaceuticals — General And Administrative Expense

Other segment segments

Similar metrics at other companies

ANABBiopharma Company — General And Administrative Expense

$18.86M+92.1%

VRTXPharmaceuticals — General and administrative expenses

$180.1M+16.0%

TRA

TRAXInternal Expense — General And Administrative Expense

$10.14M+69.9%

PLYXG&A

$1.28M+281%

MRVICygnus — G&A

$1.37M+12.8%

BEAMExternal General And Administrative Expenses — General And Administrative Expense

$13.37M+149%

Questions, answered.

What is Gyre Therapeutics, Inc.'s gyre pharmaceuticals — general and administrative expense?

Gyre Therapeutics, Inc. (GYRE) reported gyre pharmaceuticals — general and administrative expense of $4.76M in Q1 2026.

How has Gyre Therapeutics, Inc.'s gyre pharmaceuticals — general and administrative expense changed year-over-year?

Gyre Therapeutics, Inc.'s gyre pharmaceuticals — general and administrative expense increased by 33.8% year-over-year, from $3.56M to $4.76M.

What is the long-term trend for Gyre Therapeutics, Inc.'s gyre pharmaceuticals — general and administrative expense?

Over 2 years (2023 to 2025), Gyre Therapeutics, Inc.'s gyre pharmaceuticals — general and administrative expense has grown at a 23.3% compound annual growth rate (CAGR), from $8.87M to $13.49M.

What does gyre pharmaceuticals — general and administrative expense mean?

This includes the overhead costs associated with managing the business segment, such as executive compensation, legal, and administrative support functions. It is used to assess the operational leverage and cost discipline of the segment's management team.